Icahn Carl C Bausch Health Companies Inc. Transaction History
Icahn Carl C
- $7.45 Billion
- Q1 2025
A detailed history of Icahn Carl C transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Icahn Carl C holds 34,721,118 shares of BHC stock, worth $205 Million. This represents 3.02% of its overall portfolio holdings.
Number of Shares
34,721,118
Previous 34,721,118
-0.0%
Holding current value
$205 Million
Previous $280 Million
19.73%
% of portfolio
3.02%
Previous 3.8%
Shares
3 transactions
Others Institutions Holding BHC
# of Institutions
271Shares Held
243MCall Options Held
3.66MPut Options Held
11.3M-
Goldentree Asset Management LP New York, NY30.3MShares$179 Million17.26% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$156 Million9.81% of portfolio
-
Nomura Holdings Inc Tokyo, M023.4MShares$138 Million0.32% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$76.8 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$69.4 Million0.0% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.14B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...